451218
Descripción
Test por silvertip83, actualizado hace más de 1 año
|
Creado por silvertip83
hace alrededor de 11 años
|
|
Pregunta 1
Pregunta
Heterogeneous patient populations in clinical studies are a group of patients with a lot of similarities.
Respuesta
- True
- False
Pregunta 2
Pregunta
The Abstract section is the best place to find the answer to the question Why was this study conducted?
Respuesta
- True
- False
Pregunta 3
Pregunta
Who is ultimately responsible for legal issues that arise from the off-label or nonindicated use of a pharmaceutical?
Respuesta
-
the company that manufactured the product, regardless of whether or not their claims were supported by scientific evidence
-
the FDA for approving the dissemination of information regarding these off-label uses
-
the pharmaceutical sales representatives who educated the physicians on the product’s off-label uses
-
the physicians who prescribed or recommended the product to their patients
Pregunta 4
Pregunta
What is one of the differences between Phase I and Phase II clinical trials?
Respuesta
-
Phase I trials are larger than Phase II trials.
-
Phase I trials are on animals, whereas Phase II trials are on humans.
-
Phase I trials involve subjects who do not suffer from the product's target disease or symptoms.
-
Phase I trials primarily involve terminally ill patients and prisoners, whereas Phase II trials are conducted on healthy volunteers.
Pregunta 5
Pregunta
Which of the following distinguishes Phase III from Phase II trials?
Respuesta
-
Phase III is a post-approval phase.
-
Phase III trials are typically conducted at multiple sites.
-
Phase III trials involve fewer subjects.
-
Phase III trials involve safety and efficacy.
Pregunta 6
Pregunta
What is one way in which Phase IV trials differ from the other three phases of clinical trials (i.e., Phase I, Phase II, and Phase III)?
Respuesta
-
Phase IV is conducted after the drug has already received FDA approval.
-
Phase IV is the only phase in which studies are not double-blinded.
-
Phase IV studies cannot be published.
-
Phase IV studies cannot be used is medical sales representatives' sales calls.
Pregunta 7
Pregunta
What would most likely be included in the Introduction section of a clinical paper on a new product?
Respuesta
-
a description of how the subjects were selected
-
an overview of comparable products
-
data on how the subjects improved after using the new product
-
the authors' opinions on how this study should affect future research on the topic
Pregunta 8
Pregunta
What would most likely be included in the Methods section of a clinical paper on a new IOL?
Respuesta
-
a table summarizing subjects' adverse reactions to the new IOL
-
background information on the effectiveness of other types of IOLs
-
everything that another researcher would need to know in order to replicate the experiment
-
the authors' theories about why this device is more effective than other IOLs
Pregunta 9
Pregunta
Which of the following statements does NOT accurately describe a difference between statistical significance and clinical importance?
Respuesta
-
A study must be statistically significant in order to be clinically important.
-
It is possible for the results to be statistically insignificant, but actually have high clinical importance.
-
Many studies’ results are statistically significant without being clinically important.
-
The authors of clinical papers are trained and encouraged to emphasize statistical significance.
¿Quieres crear tus propios Tests gratis con GoConqr? Más información.